Call for sponsors & exhibitors
Phages 2016 invites demonstration of R&D and laboratory supplies related to virology and molecular biology and invites commercial sponsorship. You are invited to choose from a variety of highly-competitive sponsorship packages listed below. If your needs are not covered by the offered packages please contact us in the first instance and we shall do our best to develop a package to suit your requirements.
Sponsorship packages
- Gold: Includes a speaker slot AND an exhibition stand, plus four free passes (max 3)
- Silver: Includes a speaker slot OR an exhibition stand, plus three free passes (max 3)
- Bronze: Includes exhibition stand, plus two free passes (Max 3)
- Drinks Reception
- Delegate Bags (max 2)
- Delegate Badges (max 2)
- Event Documentation (max 2)
- Exhibition stand
For a Booking Form and further information about packages and other promotional opportunities email at:
Terms & Conditions of Booking.
Silver Sponsor and Exhibitor
MicroPharm Limited is a developer and manufacturer of therapeutic polyclonal antibodies for human and veterinary use. The Company’s core expertise lies in the raising of ovine antisera containing high levels of specific antibodies directed against antigens such as toxic molecules or viruses and the subsequent purification and modification of such antibodies to produce a range of immunotherapeutic products for clinical use. All are designed to treat acute, life-threatening emergencies, have been developed at the request of the medical profession and are required urgently either because no alternative exists or because any alternative is ineffective and/or unsafe. MicroPharm currently produces two antivenoms, ViperaTAb® for the treatment of envenomation by the European adder and EchiTAbG™ for the treatment of the carpet viper, Echis ocellatus. The Company has a number of products in development including: PolyCAb for the treatment of severe C. diff.; ColchiBIND for the treatment of colchicine poisoning; EBOTAb for the treatment of Ebola Virus Disease and ViperaVet™, for the treatment of dogs envenomed by one of the four medically important species of Vipera (adder) found throughout Western Europe. MicroPharm’s collaborators include Public Health England, University of Oxford, University of Leeds and the University of Edinburgh.
